Ibrahim Ince

794 total citations
22 papers, 642 citations indexed

About

Ibrahim Ince is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ibrahim Ince has authored 22 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 10 papers in Pharmacology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ibrahim Ince's work include Pharmacogenetics and Drug Metabolism (10 papers), Pharmaceutical studies and practices (10 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Ibrahim Ince is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Pharmaceutical studies and practices (10 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Ibrahim Ince collaborates with scholars based in Germany, United States and Netherlands. Ibrahim Ince's co-authors include André Dallmann, Thomas Eißing, Georg Hempel, Stefan Willmann, Catherijne A. J. Knibbe, Meindert Danhof, Saskia N. de Wildt, Michaela Meyer, Juri Solodenko and Katrin Coboeken and has published in prestigious journals such as European Heart Journal, Drug Discovery Today and Clinical Pharmacokinetics.

In The Last Decade

Ibrahim Ince

21 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ibrahim Ince Germany	14	322	216	148	130	78	22	642
Katrin Coboeken Germany	14	245 0.8×	91 0.4×	163 1.1×	142 1.1×	26 0.3×	22	701
Juri Solodenko Germany	9	206 0.6×	127 0.6×	190 1.3×	133 1.0×	38 0.5×	14	709
André Dallmann Germany	19	456 1.4×	517 2.4×	113 0.8×	100 0.8×	248 3.2×	46	1.0k
Sharon J. Gardiner New Zealand	19	254 0.8×	428 2.0×	277 1.9×	192 1.5×	107 1.4×	41	1.3k
Ganesh Cherala United States	18	230 0.7×	305 1.4×	51 0.3×	106 0.8×	119 1.5×	45	1.0k
Hany Ghabrial Australia	14	182 0.6×	101 0.5×	327 2.2×	87 0.7×	48 0.6×	47	767
Frank W.J. Gribnau Netherlands	16	189 0.6×	80 0.4×	115 0.8×	157 1.2×	30 0.4×	23	964
Cindy Woodland Canada	15	249 0.8×	89 0.4×	136 0.9×	103 0.8×	25 0.3×	23	640
Lan Tran United States	10	234 0.7×	142 0.7×	153 1.0×	91 0.7×	169 2.2×	21	528
Yi Zheng China	14	161 0.5×	84 0.4×	34 0.2×	271 2.1×	33 0.4×	65	630

Countries citing papers authored by Ibrahim Ince

Since Specialization

Citations

This map shows the geographic impact of Ibrahim Ince's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Ince with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Ince more than expected).

Fields of papers citing papers by Ibrahim Ince

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim Ince. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Ince. The network helps show where Ibrahim Ince may publish in the future.

Co-authorship network of co-authors of Ibrahim Ince

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim Ince. A scholar is included among the top collaborators of Ibrahim Ince based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim Ince. Ibrahim Ince is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sjögren, Erik, et al.. (2025). Assessing Drug–Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption. Pharmaceutics. 17(3). 314–314.

Frechen, Sebastian, Ibrahim Ince, André Dallmann, et al.. (2023). Applied physiologically‐based pharmacokinetic modeling to assess uridine diphosphate‐glucuronosyltransferase‐mediated drug–drug interactions for Vericiguat. CPT Pharmacometrics & Systems Pharmacology. 13(1). 79–92. 7 indexed citations

Tournoy, Jos, et al.. (2023). Physiologically based pharmacokinetic (PBPK) modelling of oral drug absorption in older adults – an AGePOP review. European Journal of Pharmaceutical Sciences. 188. 106496–106496. 14 indexed citations

Willmann, Stefan, Ibrahim Ince, Maurice J. Ahsman, et al.. (2022). Model‐informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease. CPT Pharmacometrics & Systems Pharmacology. 11(8). 1111–1121. 6 indexed citations

Staß, Heino, et al.. (2022). Nifurtimox for Treatment of Chagas Disease in Pediatric Patients: the Challenges of Applying Pharmacokinetic-Pharmacodynamic Principles to Dose Finding. The AAPS Journal. 24(5). 92–92. 2 indexed citations

Ince, Ibrahim, Klaas Prins, Stefan Willmann, et al.. (2022). Population Pharmacokinetics of Nifurtimox in Adult and Pediatric Patients With Chagas Disease. The Journal of Clinical Pharmacology. 62(10). 1273–1284. 3 indexed citations

Frechen, Sebastian, Juri Solodenko, Thomas Wendl, et al.. (2021). A generic framework for the physiologically‐based pharmacokinetic platform qualification of PK‐Sim and its application to predicting cytochrome P450 3A4–mediated drug–drug interactions. CPT Pharmacometrics & Systems Pharmacology. 10(6). 633–644. 26 indexed citations

Staß, Heino, et al.. (2021). Clinical investigation of the biopharmaceutical characteristics of nifurtimox tablets – Implications for quality control and application. European Journal of Pharmaceutical Sciences. 166. 105940–105940. 12 indexed citations

Ince, Ibrahim, André Dallmann, Sebastian Frechen, et al.. (2021). Predictive Performance of Physiology‐Based Pharmacokinetic Dose Estimates for Pediatric Trials: Evaluation With 10 Bayer Small‐Molecule Compounds in Children. The Journal of Clinical Pharmacology. 61(S1). S70–S82. 21 indexed citations

10.

Dallmann, André, et al.. (2020). Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after delivery. Journal of Pharmacokinetics and Pharmacodynamics. 47(4). 341–359. 18 indexed citations

11.

Frechen, Sebastian, Ibrahim Ince, André Dallmann, et al.. (2020). Physiologically-based pharmacokinetic (PBPK) exploration of extrinsic factors influencing vericiguat pharmacokinetics. European Heart Journal. 41(Supplement_2). 3 indexed citations

12.

Ince, Ibrahim, Juri Solodenko, Sebastian Frechen, et al.. (2019). Predictive Pediatric Modeling and Simulation Using Ontogeny Information. The Journal of Clinical Pharmacology. 59(S1). S95–S103. 32 indexed citations

13.

Dallmann, André, Ibrahim Ince, Michaela Meyer, et al.. (2017). Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy. Clinical Pharmacokinetics. 56(11). 1303–1330. 96 indexed citations

14.

Dallmann, André, Ibrahim Ince, Katrin Coboeken, Thomas Eißing, & Georg Hempel. (2017). A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways. Clinical Pharmacokinetics. 57(6). 749–768. 61 indexed citations

15.

Dallmann, André, Ibrahim Ince, Juri Solodenko, et al.. (2017). Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women. Clinical Pharmacokinetics. 56(12). 1525–1541. 71 indexed citations

16.

Thelen, Kirstin, Songmao Zheng, Mirjam N. Trame, et al.. (2015). Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System (BCS) class I and II compounds. British Journal of Clinical Pharmacology. 81(1). 137–147. 30 indexed citations

17.

Ince, Ibrahim, Saskia N. de Wildt, Mariska Y. M. Peeters, et al.. (2013). A Novel Maturation Function for Clearance of the Cytochrome P450 3A Substrate Midazolam from Preterm Neonates to Adults. Clinical Pharmacokinetics. 52(7). 555–565. 34 indexed citations

18.

Ince, Ibrahim, Catherijne A. J. Knibbe, Meindert Danhof, & Saskia N. de Wildt. (2013). Developmental Changes in the Expression and Function of Cytochrome P450 3A Isoforms: Evidence from In Vitro and In Vivo Investigations. Clinical Pharmacokinetics. 52(5). 333–345. 67 indexed citations

19.

Ince, Ibrahim, Saskia N. de Wildt, Mariska Y. M. Peeters, et al.. (2012). Critical Illness Is a Major Determinant of Midazolam Clearance in Children Aged 1 Month to 17 Years. Therapeutic Drug Monitoring. 34(4). 381–389. 33 indexed citations

20.

Ince, Ibrahim, Saskia N. de Wildt, Dick Tibboel, Meindert Danhof, & Catherijne A. J. Knibbe. (2008). Tailor-made drug treatment for children. Drug Discovery Today. 14(5-6). 316–320. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact